ArticleFrontiers in pharmacology2020

Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1.

Anita A Pinar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.